Abattis Bioceuticals Corp (CSE: ATT)
www.abattis.comOUR STORY Abattis is publicly traded speciality agricultural technology and biotechnology company which aggregates, integrates, and invests in agricultural technologies and biotechnology services for the legal cannabis industry developing in Canada. The Company has successfully developed and licensed natural health products, medicines, extractions, and ingredients for the biologics, nutraceutical, bioceutical, and cosmetic markets. In addition, Abattis owns one of the few Health Canada approved testing labs with a Controlled Substance License to formulate, test and develop cannabis derivatives and related products through formulation and patented extraction technologies. The Company follows strict standard operating protocols and adheres to the applicable laws of Canada and foreign jurisdictions.
Read moreOUR STORY Abattis is publicly traded speciality agricultural technology and biotechnology company which aggregates, integrates, and invests in agricultural technologies and biotechnology services for the legal cannabis industry developing in Canada. The Company has successfully developed and licensed natural health products, medicines, extractions, and ingredients for the biologics, nutraceutical, bioceutical, and cosmetic markets. In addition, Abattis owns one of the few Health Canada approved testing labs with a Controlled Substance License to formulate, test and develop cannabis derivatives and related products through formulation and patented extraction technologies. The Company follows strict standard operating protocols and adheres to the applicable laws of Canada and foreign jurisdictions.
Read moreCountry
City (Headquarters)
Vancouver
Employees
11-50
Founded
2011
Estimated Revenue
$1,000,000 to $5,000,000
Social
Employees statistics
View all employeesPotential Decision Makers
President and Chief Executive Officer
Email ****** @****.comPhone (***) ****-****
Technologies
(34)